Enzymatica AB (publ) (STO:ENZY)
Sweden · Delayed Price · Currency is SEK 1.930
-0.070 (-3.50%)
Oct 31, 2025, 12:18 PM CET
Enzymatica AB Company Description
Enzymatica AB (publ), a life science company, develops and sells medical devices for infection-related diseases.
The company’s product includes ColdZyme, a mouth spray that protects against the upper respiratory viruses that can cause cold and flu symptoms.
It also provides enzyme formulations for skin care. The company was incorporated in 2007 and is headquartered in Lund, Sweden.
Enzymatica AB (publ)
| Country | Sweden |
| Founded | 2007 |
| Industry | Drug Manufacturers - Specialty & Generic |
| Sector | Healthcare |
| Employees | 21 |
| CEO | Claus Egstrand |
Contact Details
Address: Ideon Science Park Lund, 223 70 Sweden | |
| Phone | 46 4 62 86 31 00 |
| Website | enzymatica.com |
Stock Details
| Ticker Symbol | ENZY |
| Exchange | Nasdaq Stockholm |
| Fiscal Year | January - December |
| Reporting Currency | SEK |
| ISIN Number | SE0003943620 |
| SIC Code | 2834 |
Key Executives
| Name | Position |
|---|---|
| Therese Filmersson | Chief Financial Officer and Deputy Chief Executive Officer |
| Claus Egstrand | Chief Executive Officer and Director |
| Claes Molin | Director of Operations |
| Anja Tragardh | Communications Manager |
| Anna Soderlund | Senior Director of Marketing and Sales |
| Chris Czyrko | Director of Supply, Design and Development |